Susquehanna Fundamental Investments, LLC Vbi Vaccines Inc Transaction History

Susquehanna Fundamental Investments, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$1.27 - $2.47 $31,672 - $61,599	-24,939 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$2.21 - $3.22 $340,187 - $495,657	-153,931 Reduced 86.06%	24,939 $58,000
Q3 2021 Nov 15, 2021	BUY	$2.8 - $3.72 $176,332 - $234,270	62,976 Added 54.34%	178,870 $556,000
Q2 2021 Aug 11, 2021	BUY	$2.61 - $4.17 $74,124 - $118,428	28,400 Added 32.46%	115,894 $388,000
Q1 2021 May 17, 2021	BUY	$2.91 - $4.32 $254,607 - $377,974	87,494 New	87,494 $272,000

688K

Ticker VBIV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 258,256,992
Market Cap $5.17M
Description
VBI Vaccines Inc., a biopharmaceutical company, develops and sells vaccines for the treatment of infectious diseases and immuno-oncology. The company offers Sci-B-Vac, a prophylactic hepatitis B (HBV) vaccine. It also engages in the development of VBI-2601 (BRII-179), an immunotherapeutic candidate for the treatment of chronic HBV infection. The...

Get notified when there are updates to the investment portfolio of Susquehanna Fundamental Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Susquehanna Fundamental Investments, LLC with notifications on news.